Breaking the Silence in Osteoporosis
A new international survey of 1,008 women with osteoporosis from six countries, launched on World Osteoporosis Day, reveals that while more than two-thirds (67%) of women over the age of 55 mostly understand what osteoporosis is and the potential negative impact of future fractures, 19% felt poorly informed at the time of the diagnosis.1
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211019005894/en/
The survey initiated by Theramex in cooperation with the International Osteoporosis Foundation (IOF), was conducted in Germany, France, Italy, Spain, Australia, and Brazil. It included 316 postmenopausal women over the age of 55 years and 315 premenopausal women (40-55 years) with osteoporosis (altogether 62% of the surveyed women). Of these women, osteoporosis was only diagnosed after a fracture in almost 60% of the cases. This survey highlights a gap in osteoporosis awareness, as one-fourth of the patients aged 55 years and over were not aware and did not understand the link between osteoporosis and bone fractures.1 A third (35%) of respondents said they would have been motivated to watch out for their bone health if they had known that one in three women aged over 50 will suffer a fragility fracture, but fragility fractures are preventable with the right treatment.1,2 In addition, close to 25% of postmenopausal women felt not listened to by their doctors when discussing their treatment.1
Osteoporosis is a chronic condition causing loss of bone mass and strength, resulting in fragile bones.3 It is a growing problem,3 affecting around 500 million people globally.4 Osteoporosis affects more women than men, with the risk increasing with age.5 Women are at higher risk of osteoporosis after the menopause, when the ovaries stop producing oestrogen, a hormone which has a protective effect on bones.5
Dr. Philippe Halbout, International Osteoporosis Foundation CEO said, “The impact of osteoporosis should not be underestimated. Fractures can be life-altering, causing pain, disability and loss of independence which is why it’s so important to ensure that patients are receiving the information, care and treatment they need to manage their condition and prevent or delay fractures. This survey highlights the need for improved doctor-patient communications and demonstrates the importance of education to empower women to ask for more from their care.”
Theramex CEO, Robert Stewart, commented, “Women with osteoporosis deserve support and appropriate treatment to help them continue to enjoy their lifestyles and precious moments with loved ones. We are committed to working with the osteoporosis community to provide accessible information and education about the condition, as the more women know and understand, the more they will be empowered to ask for more from their osteoporosis care, helping to reduce or eliminate the risk of fractures.”
This World Osteoporosis Day, women are being urged to #askformore from their osteoporosis care and treatment. For further information and osteoporosis resources, visit www.worldosteoporosisday.org
NOTES TO EDITOR:
About the survey1
The online survey was conducted among 1,008 women with osteoporosis across six countries: Germany (73), France (74), Spain (122), Italy (298), Australia (54) and Brazil (387). The respondents were all female with 377 under 40, 315 aged 40-54, 201 aged 55-64, 90 aged 65-75 and 25 over 75. It should be noted that the risk of osteoporosis increases with age, despite the number of women in the younger age category in this survey. The survey was conducted between 5 – 12 July 2021 by Opinion Matters on behalf of Theramex.
Osteoporosis remains largely underdiagnosed and undertreated, resulting in a large number of fractures.
- It is a significant health issue – affecting ~500 million people worldwide4
- Osteoporosis affects more women than men and risk increase with age5
- After the menopause women start to lose bone at a faster rate, raising the risk for women who have had an early menopause or hysterectomy5
- One in three women aged over 50 will suffer a fragility fracture2
- Hip, spine, and wrist fractures are the most common fractures in osteoporosis and have a debilitating impact on daily activities and quality of life2
- After a spine fracture, mortality is increased immediately after the fracture event6
- Spine fractures can lead to back pain, loss of height, deformity, immobility, impaired quality of life (QoL), and difficulties in activities of daily living7,8,9
About the International Osteoporosis Foundation (IOF)
The International Osteoporosis Foundation is the world’s largest non-governmental organization dedicated to the prevention, diagnosis, and treatment of osteoporosis and related musculoskeletal diseases.
Our vision is a world without fragility fractures, in which healthy mobility is a reality for all.
To promote bone and musculoskeletal health as a worldwide priority.
Theramex is a leading, global speciality pharmaceutical company dedicated to women and their health. With a broad portfolio of innovative and established brands covering contraception, fertility, menopause and osteoporosis, we support women at every stage of their lives. Our commitment is to listen and understand our patients, serve their needs, and offer healthcare solutions to help improve their lives. Our vision is to be a lifetime partner for women and the healthcare professionals who treat them, by providing innovative and effective solutions that care for and support women as they advance through each stage of their lives.
- Opinion Matters. (2021) #Askformore Osteoporosis International Survey.
- Cooper, C. (2019) IOF Compendium of Osteoporosis. IOF. 2nd edition.
- Noh, J.Y., Yang, Y. & Jung, H. (2020) Int J Mol Sci. 21 (20), 7623
- IOF. (n.d.) IOF website Facts and Statistics https://www.osteoporosis.foundation/facts-statistics/epidemiology-of-osteoporosis-and-fragility-fractures [Accessed 18th October 2021]
- IOF. (n.d.) About Osteoporosis: Risk Factors. Available from: https://www.osteoporosis.foundation/patients/about-osteoporosis/risk-factors [Accessed 18th October 2021]
- Johnell, O. et al. (2004) Osteoporos Int 15 (1), 38-42.
- Nevitt, M.C. et al. (1998) Ann Intern Med 128 (10), 793-800.
- Lips, P. et al (1999) Osteoporos Int 10, 150-160.
- Tosteson, A.N. et al (2001) Osteoporos Int 12:1042-1049.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alvotech and Oaktree Acquisition Corp. II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company7.12.2021 14:00:00 EET | Press release
Alvotech Holdings S.A. (“Alvotech”), a leading global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, and Oaktree Acquisition Corp. II (NYSE: OACB.U, OACB, OACB WS), a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Management, L.P. (“Oaktree”), announced today that they have entered into a definitive merger agreement. Upon completion of the transaction, the combined company’s securities are expected to be traded on NASDAQ under the symbol “ALVO.” Company Overview Alvotech, founded in 2013 in Reykjavik, Iceland, is a vertically integrated platform company focused exclusively on developing and manufacturing biosimilar medicines for the global market. Alvotech has a world class management team of proven and highly experienced pharmaceuticals executives with deep expertise in biologics and biosimilars, led by a visionary founder, Robert Wessman, who has a track record of building g
Vodafone Cook Islands Goes Live With Hansen to Accelerate Digital Transformation Programme7.12.2021 14:00:00 EET | Press release
Hansen Technologies (ASX:HSN) is pleased to announce that Vodafone Cook Islands is now live with Hansen CCB, part of the Hansen Suite for Communications Service Providers (CSPs). Hansen CCB, a tailor-made billing solution leveraging Microsoft Dynamics 365 Business Central, delivers end-to-end ‘Business in a Box’ ERP capability for CSPs around the world. Vodafone now joins Hansen’s family of over 600 global customers. Vodafone Cook Islands was looking to replace its legacy finance and billing systems with a single application, suitable for their direct, local customer base and which could also cater to their relatively large volume of short-term tourist contracts. Being a remote location, the need for a self-managed solution with extensive configuration capability, browser-based interfaces, modern integrations and demonstrated market experience was essential. Hansen CCB allows CSPs to implement and bill new communications services rapidly, and also enables the delivery of fixed and mobi
American Airlines Pilots First to Use CEFA Aviation Flight Replay App in the U.S.7.12.2021 13:16:00 EET | Press release
American Airlines, the world’s largest airline, is the first carrier in the U.S. to adopt CEFA AMS, an Electronic Flight Bag (EFB) application allowing pilots to virtually review flight data on their tablet after landing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211207005055/en/ CEFA AMS (Aviation Mobile Services) is the first self-improvement tool allowing individual pilots to access and review the specifics of their flight after landing. (Photo: Business Wire) CEFA AMS (Aviation Mobile Services) is the first self-improvement tool allowing individual pilots to access and review the specifics of their flight after landing. Captain Neil Raaz, Operations Safety Director at American Airlines, says that CEFA AMS is the next step in American’s data-driven approach to relentlessly advance safety. “By choosing CEFA AMS, we are now able to advance the Safety-II approach in a practical way in our operations. This progressive ne
FARO is Taking Care of the Healthcare of Dentists and Patients With the Solar Spectrum LED Technology – SunLike – From Seoul Semiconductor7.12.2021 13:00:00 EET | Press release
From a research study 30% of dentists will suffer from visual reduction capabilities in the next 30 years. For FARO, the solutions are already here. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211207005033/en/ Fig.1 SunLike CRI values for 6500K (Daylight) (Graphic: Business Wire) With the new dentist lamp Eva and the new ceiling panel Siderea equipped with SunLike LED technology, the historical and global market leader in the orthodontist equipment sector FARO wants to keep demonstrating their technological leadership and implement the latest technology available that can improve the healthcare of the users. FARO has developed 2 new products with edge technology that will improve patients and doctors' lives, as new products include solar spectrum light that will help on concentration, relax and recovery activities as demonstrated by recent studies done by University of Basel and Harvard medical school. The Eva lamp, compl
Roku Opens Amsterdam Office to Support International Growth7.12.2021 12:00:00 EET | Press release
Roku today announced that it is establishing and investing in an office in the city of Amsterdam. Roku plans to expand its existing presence in The Netherlands to help support its international growth. The Amsterdam office will be located on Weteringschans and offers space for up to 150 employees. Roku is headquartered in Silicon Valley in the United States, in Europe it currently has offices in Denmark, Ukraine and the United Kingdom. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211207005503/en/ Lobby at Roku office in San Jose (Photo: Business Wire) “TV streaming is a global phenomenon, and international growth is a key focus area for us,” said Arthur van Rest, VP International at Roku. “Attracting the right people is crucial to our success, and we believe that The Netherlands has great talent and expertise. We will be looking to hire across various functions, from marketing and business development to finance and legal.
Maria Teresa Hilado to Join Galderma’s Advisory Committee7.12.2021 12:00:00 EET | Press release
Galderma, the world’s largest independent dermatology company, announced today that Maria Teresa “Tessa” Hilado will join its Advisory Committee, effective January 1, 2022. Ms. Hilado currently serves on the board of directors at Campbell Soup Company, Zimmer Biomet Holdings, Inc. and Pharmaceutical Product Development, LLC. “I look forward to working with Tessa Hilado as we move forward with Galderma’s next growth phase. Her appointment will greatly strengthen the Advisory Committee and shows our dedication to increasing diversity at Galderma.” THOMAS EBELING CHAIRMAN OF THE ADVISORY COMMITTEE, GALDERMA A financial management specialist with over 30 years’ experience, Ms. Hilado brings a proven track record across several global corporations and brands. Her background includes pharmaceuticals, consumer products and industrials. She most recently served as Executive Vice President and Chief Financial Officer at global pharmaceutical company Allergan PLC, from 2014 until her retirement
Longevity Science Foundation Launches Decentralised Blockchain Voting Programme7.12.2021 11:05:00 EET | Press release
The Longevity Science Foundation (LSF) — a Swiss non-profit dedicated to advancing the healthy human lifespan — has announced today it will use blockchain technology in its funding selection process. To do so, the Foundation has created LSF Points, which will be distributed to all Foundation donators. These non-monetary tokens will empower them to vote on which projects and proposals they believe should be funded by the Foundation. All projects under consideration will first be chosen by the LSF Visionary Board for technical soundness, impact, and scientific quality. The executive summary of the programme can be found here. “Beyond having a credible, strict and transparent evaluation and selection process, the LSF wishes to accommodate a system for donors to also express their opinion and vote for their favourites among the applications,” Visionary Board Chairman Evelyne Yehudit Bischof said. “This programme will not only encourage donor involvement but will also help us achieve our mi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom